Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A MiniMed Group, Inc. Filed by: Medtronic plc

October 16, 2026 4:21 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On October 15, 2026, Medtronic plc ("Medtronic") completed the separation of MiniMed Group, Inc. (the "Issuer") through a split-off exchange offer (the "Exchange Offer"), pursuant to which Medtronic exchanged shares of common stock, par value $0.01 per share (the "Common Stock"), of the Issuer representing approximately 90% of shares of outstanding Common Stock for outstanding ordinary shares of Medtronic held by Medtronic shareholders. As a result of the Exchange Offer, Medtronic ceased to own any shares of Common Stock of the Issuer. This Amendment No. 1 to the Schedule 13G is being filed to reflect the fact that Medtronic no longer holds more than 5% of the Common Stock of the Issuer, and has ceased to be a Schedule 13G reporting person with regard to the Common Stock.


SCHEDULE 13G



Medtronic plc
Signature:/s/ Brian Sandstrom
Name/Title:Brian Sandstrom/VP, Chief Corporate and Securities Counsel
Date:10/16/2026

Categories

SEC Filings